Impact Stories | Leadership & Partnership, Health

Filter:

McMaster receives $1M to lead COVID-19 evidence network

To ensure decision-makers have access to the best COVID-19 science in a timely manner, the federal government is investing $1 million

Delivering medications by drones

Waterloo’s School of Pharmacy partners with AirMatrix to trial medication delivery

U of T researchers seek to understand the novel coronavirus on a 'deep molecular level'

SARS-CoV-2 has shut down the world by spreading furiously from one person to another. Now scientists want to trace its steps within cells to stop it.

Promising pre-clinical results for USask VIDO-InterVac COVID-19 vaccine

A COVID-19 vaccine candidate developed by the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac)

UBC scientist discovers trial drug that can significantly block early stages of COVID-19 in engineered human tissues

An international team led by UBC researcher Dr.

Standard surgical masks as good as N95 respirators for family doctors, evidence suggests

Evidence reviews of masks, goggles and shoe covers suggest individual pieces of personal protective equipment aren’t enough by themselves to protect health worke

U of T plays leading role in effort to develop COVID-19 treatment from recovered patients' blood plasma

U of A researchers and Tonix Pharmaceuticals race to develop and test candidate vaccines for COVID-19

Partnerships like this one can dramatically accelerate efforts to move research from lab to community, says virologist.

An appreciative and involved community

This content is available in French only.

Creative Destruction Lab launches COVID – 19 lab

Creative Destruction Lab The Creative Destruction Lab at @rotmanschool has launched a program to transform science and research innovations into pr